Showing results (101-110 of 270) with videos related to
Sort By:
Pageof 27
Journal of Structural Biology|March 17, 2006
Structure of bovine beta-lactoglobulin (variant A) at very low ionic strengthJulian J Adams, Bryan F Anderson, Gillian E Norris, et al.Biophysical Journal|April 23, 2013
Substrate dynamics in enzyme action: rotations of monosaccharide subunits in the binding groove are essential for pectin methylesterase processivityDavide Mercadante, Laurence D Melton, Geoffrey B Jameson, et al.Acta Crystallographica. Section D, Biological Crystallography|March 25, 1999
Structure of recombinant human lactoferrin expressed in Aspergillus awamoriX L Sun, H M Baker, S C Shewry, et al.Current Opinion in Structural Biology|December 30, 2014
Allosteric ACTion: the varied ACT domains regulating enzymes of amino-acid metabolismEric J M Lang, Penelope J Cross, Gerd Mittelstädt, et al.British Journal of Cancer|June 27, 2002
Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acidL-M Ching, Z Cao, C Kieda, et al.Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|December 16, 2019
Comparison of three oral selenium compounds in cancer patients: Evaluation of differential pharmacodynamic effects in normal and malignant cellsStephen O Evans, Gregory M Jacobson, Hugh J B Goodman, et al.Biochemistry|March 29, 2000
Structural changes accompanying pH-induced dissociation of the beta-lactoglobulin dimerS Uhrínová, M H Smith, G B Jameson, et al.Inorganic Chemistry|January 7, 2011
Toward the self-assembly of metal-organic nanotubes using metal-metal and π-stacking interactions: bis(pyridylethynyl) silver(I) metallo-macrocycles and coordination polymersKelly J Kilpin, Martin L Gower, Shane G Telfer, et al.Protein Science : a Publication of the Protein Society|April 21, 1999
Functional implications of structural differences between variants A and B of bovine beta-lactoglobulinB Y Qin, M C Bewley, L K Creamer, et al.Expert Opinion on Drug Metabolism & Toxicology|August 20, 2016
Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeuticsCatherine H Han, Dean H Kilfoyle, Andrew G Hill, et al.Pageof 27